Unknown

Dataset Information

Marked Gingival Overgrowth Protruding from the Oral Cavity Due to Sodium Valproate.


ABSTRACT: Drug-induced gingival overgrowth is associated with various systemic diseases, including epilepsy. Among antiepileptic medications, phenytoin is commonly reported to cause this condition. In contrast, sodium valproate (VPA), another widely used antiepileptic drug, rarely induces gingival overgrowth. This difference in side effects highlights the variability in drug-induced oral complications among different antiepileptic medications. This case study presents a patient who developed significant gingival overgrowth after using VPA for over 10 years. The study aims to identify VPA as the causative agent and observe changes during long-term administration and after dose reduction. Our findings demonstrate that even long-standing gingival overgrowth can improve rapidly following discontinuation

SUBMITTER: Uegami M 

PROVIDER: S-EPMC11765381 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature